IMUX · TickerCove

IMUXImmunic, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $10.12 · now $10.12 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, IMUX has typically landed between $6.95 and $14.64 — a range of −31.3% to +44.7% from the issuance price $10.12.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

3,095 overlapping 1 month windows · 2014-04-17 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($10.12) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$10.12 · 43% of range

$5.1 low$16.9 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−2.3%

typical move · IQR 28.2%

−31.3%worst (p90)+44.7%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where IMUX has typically landed a month from the 2026-09-16 close of $10.12 — the range is history, not a prediction.

now $10.12 (+0.0%)
typical $9.89 (-2.3%)
middle 50% $8.46–$11.32
90% range $6.95–$14.64

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 3,095 windows spanning 2014-04-17 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2018-08-29	−97.2%	−97.2%	+0.0%
2018-08-15	−97.1%	−97.1%	+6.4%
2018-08-28	−96.9%	−97.1%	+2.9%
3 best
2019-03-13	+256.2%	−16.7%	+256.2%
2019-03-12	+240.7%	−14.2%	+240.7%
2019-03-07	+229.9%	−12.2%	+229.9%

3,095 overlapping windows · 2014-04-17 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

50%

+6.1%

n=12

Feb

42%

+6.2%

n=12

Mar

33%

−3.4%

n=12

Apr

25%

+2.6%

n=12

May

15%

−4.4%

n=13

Jun

62%

+12.6%

n=13

Jul

54%

+4.3%

n=13

Aug

62%

−2.9%

n=13

Sep

46%

−9.5%

n=13

Oct

33%

−3.5%

n=12

Nov

50%

−0.2%

n=12

Dec

58%

+2.1%

n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2025-06-13	Nash Duane	director	Purchase	20,000 @ $0.83	$17K	+124.8% of holding	+6.4%	−37.6%	36,032	Form 4 · filed 3 days after the trade
2025-06-05	Neermann Joerg	director	Purchase	30,000 @ $0.76	$23K	+17.6% of holding	+2.3%	−27.1%	200,000	Form 4 · filed same day
2025-06-05	Tardio Jason	officer	Purchase	12,512 @ $0.79	$10K	ownership Δ n/a	+2.3%	−27.1%	12,512	Form 4 · filed 4 days after the trade
2025-06-04	Neermann Joerg	director	Purchase	70,000 @ $0.77	$54K	+70.0% of holding	−5.8%	−31.5%	170,000	Form 4 · filed 1 day after the trade
2025-06-04	Vitt Daniel	director	Purchase	15,000 @ $0.77	$12K	+107.1% of holding	−5.8%	−31.5%	29,000	Form 4 · filed 2 days after the trade
2025-06-03	Rudick Richard Alan	director	Purchase	143,075 @ $0.70	$100K	+163.9% of holding	−5.6%	−25.7%	230,375	Form 4 · filed 1 day after the trade
2025-06-03	Whaley Glenn	officer	Purchase	45,000 @ $0.71	$32K	+89.1% of holding	−5.6%	−25.7%	95,510	Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

45 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-06	Ridloff Elena	director	Award / grant	50,740	50,740	Form 4
2026-07-05	Rudick Richard Alan	director	Award / grant	25,370	25,370	Form 4
2026-07-05	Skerjanec Simona	director	Award / grant	25,370	25,370	Form 4
2026-07-05	Neermann Joerg	director	Award / grant	25,370	25,370	Form 4
2026-07-05	PHILLIPS BARCLAY A	director	Award / grant	25,370	25,370	Form 4
2026-07-05	Congleton Jon	director	Award / grant	25,370	25,370	Form 4
2026-06-29	PHILLIPS BARCLAY A	director	Award / grant	25,370	25,370	Form 4
2026-06-29	Neermann Joerg	director	Award / grant	25,370	25,370	Form 4
2026-06-29	Rudick Richard Alan	director	Award / grant	25,370	25,370	Form 4
2026-06-29	Skerjanec Simona	director	Award / grant	25,370	25,370	Form 4
2026-06-29	Vitt Daniel	director	Award / grant	445,000	445,000	Form 4
2026-06-29	BONNEY MICHAEL W	director	Award / grant	100,000	100,000	Form 4
2026-06-29	Congleton Jon	director	Award / grant	50,740	50,740	Form 4
2026-06-29	HOWSON TAMAR D	director	Award / grant	25,370	25,370	Form 4
2026-06-29	Whaley Glenn	officer	Award / grant	120,000	120,000	Form 4
2026-06-29	Tardio Jason	officer	Award / grant	253,000	253,000	Form 4
2026-05-22	Lundgren Erik	officer	Award / grant	1,000,000	1,000,000	Form 4
2026-04-24	Panzara Michael A.	director	Award / grant	300,000	300,000	Form 4
2025-07-16	Tardio Jason	officer	Award / grant	330,000	330,000	Form 4
2025-07-16	Whaley Glenn	officer	Award / grant	280,000	280,000	Form 4
2025-07-16	Whaley Glenn	officer	Award / grant	560,000	560,000	Form 4
2025-07-16	Tardio Jason	officer	Award / grant	660,000	660,000	Form 4
2025-07-16	Muehler Andreas	officer	Award / grant	330,000	330,000	Form 4
2025-07-16	Muehler Andreas	officer	Award / grant	660,000	660,000	Form 4
2025-07-16	Vitt Daniel	director	Award / grant	860,000	860,000	Form 4
2025-07-16	Vitt Daniel	director	Award / grant	1,720,000	1,720,000	Form 4
2025-07-16	Nash Duane	director	Award / grant	315,000	315,000	Form 4
2025-07-16	Nash Duane	director	Award / grant	630,000	630,000	Form 4
2025-06-05	Nash Duane	director	Award / grant	560,000	560,000	Form 4
2025-06-05	Whaley Glenn	officer	Award / grant	503,000	503,000	Form 4
2025-06-05	Neermann Joerg	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Toernsen Monika Maria	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Rudick Richard Alan	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Skerjanec Simona	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Tardio Jason	officer	Award / grant	595,000	595,000	Form 4
2025-06-05	PHILLIPS BARCLAY A	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Muehler Andreas	officer	Award / grant	595,000	595,000	Form 4
2025-06-05	HOWSON TAMAR D	director	Award / grant	150,000	150,000	Form 4
2025-06-05	Vitt Daniel	director	Award / grant	1,535,000	1,535,000	Form 4
2025-05-30	Whaley Glenn	officer	Award / grant	25,000	50,510	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i